During follow-up, the patient again presented symtoms of nausea, general discomfort and anxiety, and on day seven she decided to reduce, of her own accord, the dose of naltrexone to 25 mg/day.
Durante su evolución ambulatoria, la paciente presenta nuevamente síntomas de náuseas, malestar general y ansiedad, y al séptimo día decide disminuir el tratamiento a 25 mg de naltrexona al día.